Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
5.70
+0.02 (0.35%)
Oct 8, 2025, 2:23 PM EDT - Market open
Precision BioSciences Market Cap
Precision BioSciences has a market cap or net worth of $67.19 million as of October 8, 2025. Its market cap has decreased by -3.35% in one year.
Market Cap
67.19M
Enterprise Value
34.15M
1-Year Change
-3.35%
Ranking
Category
Stock Price
$5.70
Market Cap Chart
Since March 28, 2019, Precision BioSciences's market cap has decreased from $855.07M to $67.19M, a decrease of -92.14%. That is a compound annual growth rate of -32.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 66.95M | 129.07% |
| Dec 31, 2024 | 29.23M | -34.32% |
| Dec 29, 2023 | 44.50M | -66.30% |
| Dec 30, 2022 | 132.04M | -70.64% |
| Dec 31, 2021 | 449.68M | 2.74% |
| Dec 31, 2020 | 437.69M | -37.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |